Elepsia XR and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Elepsia XR and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: levetiracetam
Brand name: Keppra, Keppra XR, Roweepra, Spritam, Roweepra XR
Synonyms: n.a.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Elepsia XR-Insulin glargine, recombinant Subcutaneous
- Elepsia XR-Insulin glulisine
- Elepsia XR-Insulin Glulisine (Cartridges and Pens)
- Elepsia XR-Insulin Glulisine (Vials)
- Elepsia XR-Insulin glulisine Subcutaneous
- Elepsia XR-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Elestrin
- Insulin glargine and lixisenatide Subcutaneous-Elestrin Transdermal
- Insulin glargine and lixisenatide Subcutaneous-Eletriptan
- Insulin glargine and lixisenatide Subcutaneous-Eletriptan Hydrobromide
- Insulin glargine and lixisenatide Subcutaneous-Elexacaftor, Tezacaftor and Ivacaftor
- Insulin glargine and lixisenatide Subcutaneous-Elfolate